News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

HemoSense, Inc. (HEM) Receives Patent Infringement Notification from Beckman Coulter, Inc. (BEC)



10/19/2007 11:53:57 AM

SAN JOSE, Calif.--(BUSINESS WIRE)--HemoSense, Inc. (AMEX:HEM) today announced that Beckman Coulter, Inc. ("Beckman") has filed a complaint in the United States District Court for the Northern District of California, alleging that HemoSense is infringing a patent held by Beckman, relating to the HemoSense INRatio® system. Beckman is seeking injunctive relief as well as unspecified damages. HemoSense believes it has meritorious defenses against the claims raised by Beckman and intends to defend itself vigorously.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES